fda warning letters compounded semaglutide september 2025 Article: Brazilian Clinics and the False Equivalence of GLP-1 Drugs: ANVISA should follow FDA ramps up its pushback

For some of the drugs, we know the biochemistry is not the same. (Theres also a legal battle going on between brand-name drug makerswhose patents havent expired yetand the compounders and telehealth companies selling their own versions

The speed and magnitude of response to GLP-1 therapy varies significantly between individuals due to multiple physiological and practical factors

Avoid injecting into broken skin, scar tissue, bruised or infected areas, moles, or sites showing signs of lipohypertrophy

But you may not notice a change to your appetite after your first dose, cautions Dr

doi: 10.1210/jendso/bvad016

For a surgery where the aesthetic outcome depends on a stable facial envelope a chin procedure, a maxillomandibular advancement, a TMJ reconstruction future weight changes can shift how things look down the road